Pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research across antimicrobial resistance, tobacco harm reduction and smoking cessation, and pandemic preparedness, with a focus on health systems, policy, and population-level risk.
About
Yusuff Adebayo Adebisi is a pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research. He serves as Director of Research at Global Health Focus, leading applied research and capacity-strengthening initiatives across the Global South.
His work focuses on antimicrobial resistance, tobacco harm reduction, and pandemic preparedness, with a strong emphasis on real-world evidence, administrative data, and translating science into policy impact. He actively promotes bidirectional knowledge exchange between the Global North and South.

Explore
Research, career, funding and recognition.
Blog
Thoughts on public health, equity, global health policy, and more.
21 November 2026
A systematic review and meta-analysis of 43 observational studies with more than 35,000 participants found that people with a smoking history had 66% higher odds of antibiotic-resistant infection — with the evidence concentrated in drug-resistant tuberculosis.
Read article →21 November 2026
A longitudinal study of 18,802 UK adults in Understanding Society found a 43% higher adjusted risk of newly diagnosed arthritis among exclusive cigarette smokers and a 79% higher risk among dual users — but no clear association among exclusive e-cigarette users.
Read article →23 October 2026
A systematic review and meta-analysis of 60 human studies found that every pooled toxicant biomarker was lower after smokers switched completely to e-cigarettes — with estimated reductions ranging from 61% for NNAL to 92% for NNN — while dual use produced smaller and more variable reductions.
Read article →Contact
I welcome enquiries about research collaborations, speaking engagements, peer review, consultancy, or mentorship. Don't hesitate to reach out.